GSK2188931B is a novel and potent soluble epoxide hydrolase (sEH) inhibitor. sEH inhibition exerts beneficial effects on cardiac function and ventricular remodeling post-MI, and direct effects on fibrosis and hypertrophy in cardiac cells.
MedKoo Cat#: 522543
Name: GSK2188931B
CAS#: Unknown
Chemical Formula: C19H22BrF3N6O2
Exact Mass: 502.0940
Molecular Weight: 503.32
Elemental Analysis: C, 45.34; H, 4.41; Br, 15.88; F, 11.32; N, 16.70; O, 6.36
The following data is based on the product molecular weight 503.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
